EMA — authorised 18 December 2018
- Marketing authorisation holder: Lupin Europe GmbH
- Status: approved
EMA authorised Mexitil on 18 December 2018
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 18 December 2018.
Lupin Europe GmbH holds the EU marketing authorisation.